Clinical Trials Directory

Trials / Completed

CompletedNCT04657588

Controlling Faecal Incontinence With a Novel Anal Device: a Cost-effectiveness Trial

Controlling Faecal Incontinence With a Novel Anal Device: a Cost-effectiveness Trial (CONFIDEnCE)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
73 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
16 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the cost-effectiveness and improvement in quality of life of using a novel anal insert (navina)

Detailed description

After being informed about the study including the potential pros and cons, patients will be given a minimum of 7 days to think about whether they would like to participate in the study. If they would like to participate, and informed consent form will need to be signed, after which the patients will undergo a screening to ensure they meet the inclusion criteria. A 2 week run-in period will take place to let patients get used to filling in an electronic daily diary. Prior to this period, patients will be asked to fill out several questionnaires. After this period, randomisation into either (1) the anal insert group or (2) the care as usual group. Group 1 will then have an 'accommodation' week in which they can try out two different sizes of the anal insert to see which size they would prefer for the treatment period. The treatment period will consist of 8 weeks In which the (1) anal insert group is expected to use the anal inserts and the (2) care as usual group is asked to continue with their treatment as usual. During the treatment period, patients will fill out an electronic daily diary as well as weekly questionnaires.At the end of the 8 week treatment period, patients will fill out additional questionnaires. The follow-up consists of 4 weeks, after which patients will be asked again to fill out several questionnaires.

Conditions

Interventions

TypeNameDescription
DEVICENavina anal insertThe Navina anal device is a single-use, pre-lubricated, liquid-filled rectal insert with a plastic applicator. The insert is filled with liquid mineral oil. The primary advantage of this new instrument is the fact that the liquid-filled insert will move and adapt as the fluid is transferred throughout the device making it easy to insert/remove and comfortable to wear. The design is intended to adjust to the contours of the individual anatomy to prevent leakage.
OTHERCare as usualCare as usual means participants are to continue their usual treatment for FI, like they would if they would not have participated in this study.

Timeline

Start date
2021-06-06
Primary completion
2024-08-01
Completion
2024-08-01
First posted
2020-12-08
Last updated
2025-12-18

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT04657588. Inclusion in this directory is not an endorsement.